Article Details
Retrieved on: 2021-03-27 01:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The ADNAB platform will make use of Sorrento's G-MAB library of fully humanized monoclonal antibodies, which makes itwell-placed to deliver an ...
Article found on: fintechzoom.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here